Research map: A Qualitative Study of Perceived Barriers to Hepatitis C Care Delivery Among Health Providers in Washington State

Back to the article

Papers in this map

  1. Three Approaches to Qualitative Content Analysis · Hsiu-Fang Hsieh · 2005 · 45270 citations · Cited by this paper
  2. Development and Validation of a Self-Efficacy Scale for Patients With Colorectal Cancer Surgery · 2026 · Related
  3. Standards for Reporting Qualitative Research · Bridget C. OʼBrien · 2014 · 12490 citations · Cited by this paper
  4. Ethical Issues Perceived by Nurses Involved in Endoscopic Practices in Japan · 2026 · Related
  5. The updated Consolidated Framework for Implementation Research based on user feedback · Laura J. Damschroder · 2022 · 4381 citations · Cited by this paper
  6. Musculoskeletal Pain and Injury in Nurses and Technicians Assisting With Endoscopic Retrograde Cholangiopancreatography (ERCP) · 2026 · Related
  7. Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection · Jordan J. Feld · 2015 · 1128 citations · Cited by this paper
  8. The Effect of Mobile Application-Based Training on Bowel Preparation Quality in Pre-Colonoscopy Patients · 2026 · Related
  9. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection · Graham R. Foster · 2015 · 860 citations · Cited by this paper
  10. Bridging the Gap: The Need for a Nurse-Led Transition-of-Care Education Program to Improve Outcomes for Pediatric Patients on Home Parenteral Nutrition (HPN) · 2026 · Related
  11. Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection · Stefan Zeuzem · 2018 · 446 citations · Cited by this paper
  12. Preparation for Pediatric Gastrointestinal Endoscopy · 2026 · Related
  13. Glecaprevir plus pibrentasvir for chronic hepatitis C virus genotype 1, 2, 4, 5, or 6 infection in adults with compensated cirrhosis (EXPEDITION-1): a single-arm, open-label, multicentre phase 3 trial · Xavier Forns · 2017 · 348 citations · Cited by this paper
  14. An Overview of Nonalcoholic Fatty Liver Disease With Current Treatment Strategies · 2026 · Related
  15. Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection · Debika Bhattacharya · 2023 · 297 citations · Cited by this paper
  16. HELPING PATIENTS UNDERSTAND HOW SCIENCE WORKS AND WHY IT MATTERS · 2026 · Related
  17. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs · Elana S. Rosenthal · 2020 · 129 citations · Cited by this paper
  18. STRENGTHENING OUR GLOBAL VOICE · 2026 · Related
  19. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis · Afia Amoako · 2021 · 101 citations · Cited by this paper
  20. The Physical and Psychosocial Adaptation Experiences of Youths Diagnosed with Biliary Atresia and Treated Using the Kasai Procedure at Infancy · 2026 · Related
  21. Hepatitis C treatment uptake among people who inject drugs in the oral direct‐acting antiviral era · Oluwaseun O Falade-Nwulia · 2020 · 61 citations · Cited by this paper
  22. Leveraging the electronic health record to eliminate hepatitis C: Screening in a large integrated healthcare system · Alexander G. Geboy · 2019 · 26 citations · Cited by this paper
  23. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs · J.I. Tsui · 2023 · 15 citations · Cited by this paper
  24. Understanding healthcare engagement for people who inject drugs · Omeid Heidari · 2023 · 14 citations · Cited by this paper
  25. Does a simplified algorithm and integrated HCV care model improve linkage to care, retention, and cure among people who inject drugs? A pragmatic quality improvement randomized controlled trial protocol · Stacey L. Klaman · 2024 · 7 citations · Cited by this paper
  26. The State of Hepatitis C Elimination from the Front Lines: A Qualitative Study of Provider-Perceived Gaps to Treatment Initiation · Christopher J Gonzalez · 2024 · 6 citations · Cited by this paper
  27. Provider reported implementation barriers to hepatitis C elimination in Washington State · Paula Cox‐North · 2024 · 6 citations · Cited by this paper
  28. Untitled · Cited by this paper

Source: OpenAlex (CC0)